Vera Therapeutics, Inc. | License Agreements | Business Contracts

Amendment to License Agreement, dated September 9, 2022, by and between the Company and Novartis Pharma AG (Filed With SEC on September 9, 2022)

Amendment No. 1 to License Agreement between Novartis International Pharmaceutical AG and Amplyx Pharmaceuticals, Inc. dated September 24, 2019 (Filed With SEC on February 7, 2022)

License Agreement between Novartis International Pharmaceutical AG and Amplyx Pharmaceuticals, Inc. dated August 26, 2019 (Filed With SEC on February 7, 2022)

License Agreement by and between the Registrant and Ares Trading S.A., dated as of October 29, 2020 (Filed With SEC on April 23, 2021)

Vera Therapeutics, Inc. (31) | License Agreements (4)